Back to Authors

Gallion, Holly H.

A5022568848 | I1330342723

Mayo Clinic

Citations 3

An ex vivo chemoresponse assay predicts carboplatin-induced progression-free interval in ovarian cancer

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5134-5134

10.1200/jco.2004.22.90140.5134

Ex vivo chemoresponse assay of ovarian cancers predicts clinical outcome

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5074-5074

10.1200/jco.2004.22.90140.5074

Heterogeneity in chemoresponsiveness of ovarian cancer as demonstrated by an ex vivo chemo response assay

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5059-5059

10.1200/jco.2004.22.90140.5059